CINECA IRIS Institutional Research Information System

FALCONE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.276
AS - Asia 8.110
EU - Europa 3.701
SA - Sud America 1.762
AF - Africa 335
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 28.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.895
SG - Singapore 2.970
HK - Hong Kong 1.589
CN - Cina 1.567
BR - Brasile 1.394
IT - Italia 1.073
VN - Vietnam 703
BG - Bulgaria 515
SE - Svezia 429
DE - Germania 359
GB - Regno Unito 293
FR - Francia 269
IN - India 254
RU - Federazione Russa 230
CA - Canada 227
TR - Turchia 206
FI - Finlandia 130
JP - Giappone 129
BD - Bangladesh 128
AR - Argentina 105
IQ - Iraq 100
CI - Costa d'Avorio 67
MX - Messico 66
SA - Arabia Saudita 62
ZA - Sudafrica 62
VE - Venezuela 59
NL - Olanda 57
KR - Corea 53
PK - Pakistan 53
AT - Austria 50
EC - Ecuador 49
PL - Polonia 46
CO - Colombia 43
ID - Indonesia 42
ES - Italia 39
MA - Marocco 39
UA - Ucraina 35
PH - Filippine 34
CZ - Repubblica Ceca 32
KE - Kenya 32
UZ - Uzbekistan 31
CH - Svizzera 28
SN - Senegal 28
CL - Cile 27
PY - Paraguay 26
JO - Giordania 25
AE - Emirati Arabi Uniti 22
TN - Tunisia 22
PE - Perù 21
UY - Uruguay 21
EG - Egitto 20
IE - Irlanda 19
AU - Australia 18
JM - Giamaica 16
NG - Nigeria 16
NP - Nepal 16
AZ - Azerbaigian 14
TT - Trinidad e Tobago 14
HU - Ungheria 13
MY - Malesia 12
BE - Belgio 11
DZ - Algeria 11
ET - Etiopia 11
IL - Israele 11
AL - Albania 10
BO - Bolivia 10
KZ - Kazakistan 10
LT - Lituania 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
HN - Honduras 8
IS - Islanda 8
OM - Oman 8
CR - Costa Rica 7
EU - Europa 7
GE - Georgia 7
GT - Guatemala 7
LY - Libia 7
PA - Panama 7
AO - Angola 6
BB - Barbados 6
LB - Libano 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
BH - Bahrain 5
GR - Grecia 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
GY - Guiana 4
IR - Iran 4
KH - Cambogia 4
KW - Kuwait 4
SV - El Salvador 4
TH - Thailandia 4
KG - Kirghizistan 3
NI - Nicaragua 3
RO - Romania 3
Totale 28.159
Salva come PNG Salva come JPEG
Città #
Singapore 1.724
Hong Kong 1.582
Ashburn 1.546
Dallas 1.507
Fairfield 1.208
Santa Clara 901
San Jose 874
Chandler 656
Shanghai 598
Woodbridge 555
Boulder 524
Sofia 514
Seattle 513
Houston 469
Wilmington 412
Cambridge 407
New York 370
Boardman 292
Beijing 261
Los Angeles 243
Milan 233
Princeton 231
Lawrence 215
Lauterbourg 199
Ho Chi Minh City 176
Council Bluffs 175
Des Moines 165
Ann Arbor 156
Medford 153
Istanbul 142
Hanoi 134
Ottawa 134
Munich 120
Florence 117
São Paulo 112
Tokyo 108
London 100
Redondo Beach 93
Frankfurt am Main 90
San Diego 87
Pisa 77
Buffalo 70
Abidjan 67
Helsinki 67
Rome 64
Dong Ket 62
Chicago 54
Serra 54
Bremen 52
Ogden 52
Rio de Janeiro 52
Nanjing 47
Seoul 47
Columbus 46
Hefei 46
Nuremberg 42
Baghdad 41
Turku 41
Belo Horizonte 40
Hyderabad 37
The Dalles 35
Vienna 35
Warsaw 34
Brasília 31
Stockholm 29
Dakar 28
Nairobi 28
Pune 28
Tashkent 27
Brooklyn 26
Brno 25
Dhaka 25
Haiphong 25
Hebei 25
Johannesburg 25
Da Nang 24
Redwood City 24
Atlanta 23
Curitiba 23
Riyadh 23
Nanchang 22
Orem 22
Phoenix 22
Toronto 22
Amman 21
Fuzhou 21
Porto Alegre 21
Changsha 20
Denver 20
Tianjin 20
Jeddah 19
Zurich 19
Dearborn 18
Falls Church 18
Lappeenranta 18
Manchester 18
Ankara 17
Düsseldorf 17
Guayaquil 17
Montreal 17
Totale 20.086
Salva come PNG Salva come JPEG
Nome #
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 227
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 223
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 222
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 214
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 214
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 194
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 190
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 189
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 189
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 184
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 182
A rare case of mycobacterial pseudoaneurysm of the superficial femoral artery 180
Pharyngeal and cutaneous diphtheria: a tail of a refugee 176
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 173
Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians 172
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 172
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 170
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 169
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 161
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 158
Physical, Mental and Sexual Health Among Transgender Women. A comparative Study Among Operated Transgender and Cisgender Women in a National Tertiary Referral Network 155
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 154
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia 150
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 148
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 147
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 146
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis 144
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study 143
Healthcare-associated pneumonia: a never-ending story 142
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 141
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 141
Clinical experience of anidulafungin for the treatment of patients with documented candidemia 140
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy 140
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 139
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study 138
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis 138
Candidaemia after heart valve replacement surgery: recurrence as prosthetic valve endocarditis is an expected over one-year complication 137
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 137
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 137
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: An exploratory pilot study 136
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 132
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 132
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 131
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study 131
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 130
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia? 130
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia 130
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 129
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 129
Surveillance and management of multidrug-resistant microorganisms 128
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 127
Platelet activation is associated with myocardial infarction in patients with pneumonia 127
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 127
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 126
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 126
Cirrhotic patients are at risk for health care-associated bacterial infections 126
Diabetes and acute bacterial skin and skin structure infections 126
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 126
Pneumonia in frail older patients: An up to date 125
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 125
Candidal thrombophlebitis of central veins: case report and review 125
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 125
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections 125
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 124
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 124
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 123
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 123
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia 123
Performance status and in-hospital mortality of elderly patients with community acquired pneumonia 123
Native-Valve Aspergillus Endocarditis: Case Report and Literature Review 122
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 122
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 122
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 122
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 121
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae 121
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 121
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 120
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 120
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 119
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 119
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature 119
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial 119
Invasive aspergillosis in patients with liver disease 118
Early identification of severe community-onset pneumonia in "frail elderly patient" 118
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 118
Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification 118
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection 117
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 117
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 117
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 116
Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature 116
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 115
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort 115
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 115
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia 114
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 114
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 114
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey 114
Management of COVID patients with convalescent plasma: Do we have the final word? 114
Identification and management of invasive mycoses in internal medicine: a road-map for physicians 113
Totale 13.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 0 0 0 0 0 125 249
2021/20222.120 70 122 69 98 381 312 125 126 101 43 149 524
2022/20232.273 295 188 161 209 264 340 35 190 365 10 172 44
2023/20241.746 118 141 153 94 236 369 147 50 31 16 114 277
2024/20257.968 59 304 66 477 585 841 631 367 758 954 719 2.207
2025/20269.344 510 920 1.426 1.272 893 818 1.319 433 696 840 217 0
Totale 28.708